A reappraisal of the benefit ‐risk profile of hydroxyurea in polycythemia vera: A propensity‐matched study

In conclusion, this analysis provides reliable and qualified estimates of the therapeutic profile of HU and PHL treatments for future experimental studies and for the management of PV in clinical practice.

Source: American Journal of Hematology - July 29, 2017 Category: Hematology Authors: Tiziano Barbui, Alessandro Maria Vannucchi, Guido Finazzi, Maria Chiara Finazzi, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Gianni Tognoni Tags: RESEARCH ARTICLE Source Type: research